Skip to navigation Skip to content



New data published from Canadian CCSVI prevalence study

October 8, 2013

Results from a Canadian research study investigating the prevalence of CCSVI in MS and others was published early online on October 8, 2013 in the medical journal The Lancet. The team led by Dr. Anthony Traboulsee, University of British Columbia, with Dr. Katherine Knox, director of the Saskatoon MS clinic, was among seven teams supported by a joint initiative by the National MS Society and the MS Society of Canada.

Read details about this study on the MS Society of Canada’s Website.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


Your input is important!

We believe that people affected by MS live better lives when they're connected.  To help us provide you with the best resources, support and information, please provide your feedback in a short survey.
Take the survey